FDA Panel Votes 21-16 To Recommend Lowering Maximum Daily Dosage of Johnson & Johnson's (JNJ) Tylenol

June 30, 2009 12:20 PM EDT

FDA Panel Votes 21-11 to recommend switch Johnson & Johnson (NYSE: JNJ) max dose of Tylenol to prescription only.
FDA Panel Votes 24-13 To Recommend limiting single dosage to 650mg
FDA Panel Votes 21-16 to recommend lower maximum daily dosage of Tylenol


Related Categories

FDA
Hot List

Stocks Mentioned

JNJ 64.36

+0.20 +0.31%
Volume: 14,992,556
Track JNJ


Add Your Comment